Incannex Healthcare (IXHL) Shares Issued (2023 - 2026)
Incannex Healthcare (IXHL) posted quarterly Shares Issued of $3939.0 for Q1 2026, down 98.32% year-on-year from $235008.0 in Q1 2025, and down 96.67% on a QoQ basis from $118173.0 in Q4 2025.
Incannex Healthcare (IXHL) Shares Issued (2023 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Shares Issued for 4 consecutive years, with $3939.0 the latest figure, recorded in Q1 2026.
- Quarterly Shares Issued fell 98.32% year-over-year to $3939.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3939.0 (down 98.32% YoY) and the FY2025 annual result came in at $3939.0, down 48.06% from the prior year.
- Shares Issued declined to $3939.0 in Q1 2026 per IXHL's latest filing, from $118173.0 in the prior quarter.
- Over the last five years, Shares Issued for IXHL reached as high as $633508.0 in Q2 2023 and fell as low as $3939.0 in Q2 2025.
- A 4-year average of $232655.3 and a median of $235008.0 in 2024 frame the typical range for Shares Issued.
- The largest YoY upside for Shares Issued was 17.25% in 2024 against a maximum downside of 98.8% in 2024.
- Year by year, Shares Issued stood at $284008.0 in 2023, then decreased by 17.25% to $235008.0 in 2024, then sank by 49.72% to $118173.0 in 2025, then slumped by 96.67% to $3939.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $3939.0, $118173.0, and $118173.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Incannex Healthcare | 37.29 Mn | 37.29 Mn | - | 3,939.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,939.00 |
| Mar 31, 2026 | 3,939.00 |
| Dec 31, 2025 | 118,173.00 |
| Dec 31, 2025 | 118,173.00 |
| Sep 30, 2025 | 118,173.00 |
| Sep 30, 2025 | 118,173.00 |
| Jun 30, 2025 | 3,939.00 |
| Jun 30, 2025 | 3,939.00 |
| Mar 31, 2025 | 235,008.00 |
| Mar 31, 2025 | 235,008.00 |
| Dec 31, 2024 | 235,008.00 |
| Dec 31, 2024 | 235,008.00 |
| Sep 30, 2024 | 235,008.00 |
| Sep 30, 2024 | 235,008.00 |
| Jun 30, 2024 | 7,584.00 |
| Jun 30, 2024 | 7,584.00 |
| Mar 31, 2024 | 284,008.00 |
| Mar 31, 2024 | 284,008.00 |
| Dec 31, 2023 | 284,008.00 |
| Dec 31, 2023 | 284,008.00 |